Spatial transcriptomic analyses corroborated these findings, demonstrating that RAC1 expression is spatially confined to tumor core regions, thereby implicating RAC1 as a central player in shaping the tumor microenvironment and possibly influencing treatment responses through localized immunosuppression or immune modulation. Here, RAC1 is linked to neoplasm.